Upgrade to SI Premium - Free Trial

Medtronic (MDT) Granted FDA Breakthrough Designation for Developing Personalized Closed Loop Insulin Pump System for Diabetes Management

February 19, 2019 6:58 AM
Medtronic plc (NYSE: MDT) today announced it has received Breakthrough Device designation from the U.S. Food and Drug Administration (FDA) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles